EXFORGE HCT cpr pell 5mg/160mg/12.5mg 28 pce

7680594070011 CH-59407 C09DX01 02.07.2.

Reimbursement limitations:

EXFORGE HCT

Le traitement combiné d'EXFORGE HCT et d'un antagoniste du calcium I.T. 02.06 et/ou d'un inhibiteur …

EXFORGE HCT cpr pell 5mg/160mg/12.5mg 28 pce
EXFORGE HCT cpr pell 5mg/160mg/12.5mg 28 pce
EXFORGE HCT cpr pell 5mg/160mg/12.5mg 28 pce
1 / 3
google

Details

Product number
5940701
CPT
-
Packaging group
28
Unit
Tablette(n)
Composition
amlodipinum 5 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, talcum, E 171, pro compresso obducto.

Articles (1)

Exforge HCT 5 mg/160 mg/12.5 mg, Filmtabletten
Filmtabletten
28
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Professional SmPC
Allemand
27/06/2025
Professional SmPC
Français
27/06/2025
Professional SmPC
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
160.0 MG Substance Wirkstoff (Principe actif)
(N/A)
12.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Reimbursement information

Public price
CHF 39.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2009

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
59407
Drug name
Exforge HCT, Filmtabletten
Galenic form
FILM
ATC Code
C09DX01
Authorization status
Z
Dispensation category
B
First authorization
16/09/2009
Authorization expiration date
31/12/9999
IT number
02.07.2.
Domain
Human medicine
Field of application
Essentielle Hypertonie

Packaging details

Description (FR)
EXFORGE HCT cpr pell 5mg/160mg/12.5mg 28 pce
Description (DE)
EXFORGE HCT Filmtabl 5mg/160mg/12.5mg 28 Stk
Market launch
16/09/2009
Narcotic (BTM)
No

Available generics

Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
CHF 33.35
View
Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
CHF 75.65
View
Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
CHF 76.80
View
Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
CHF 33.35
View
Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
CHF 75.65
View
Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
CHF 76.80
View
Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
CHF 33.35
View
Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
CHF 75.65
View
Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
CHF 76.80
View
Amlodipin-Valsartan-HCT-Mepha, Filmtabletten
CHF 33.35
View

Other packaging sizes

EXFORGE HCT cpr pell 5mg/160mg/12.5mg 98 pce
98 TABL
View
EXFORGE HCT cpr pell 10mg/160mg/12.5mg 28 pce
28 TABL
View
EXFORGE HCT cpr pell 10mg/160mg/12.5mg 98 pce
98 TABL
View
EXFORGE HCT cpr pell 5mg/160mg/25mg 28 pce
28 TABL
View
EXFORGE HCT cpr pell 5mg/160mg/25mg 98 pce
98 TABL
View
EXFORGE HCT cpr pell 10mg/160mg/25mg 28 pce
28 TABL
View
EXFORGE HCT cpr pell 10mg/160mg/25mg 98 pce
98 TABL
View